Sophie is an experienced healthcare communications professional and provides strategic counsel as part of the senior leadership team at Biosector 2 and the wider inVentiv Health PR group in London. Sophie’s experience spans multiple therapy areas and UK, pan-European, and Global healthcare and consumer communications both at inVentiv Health and in house, with a focus on media and unbranded programs. Sophie also takes a lead on integrated communications across inVentiv Health and alongside this, is particularly passionate about team engagement, company culture and corporate social responsibility. A keen linguist, Sophie’s love of languages has fueled her passion for a career in communications.
B2 is part of INC Research/inVentiv Health, an industry-changing new company, purpose-built to help the industry achieve a singular goal: Biopharmaceutical Acceleration. The coming together of two dedicated businesses allows us to address new market realities through clinical and commercial sharing expertise, data and insights to meet the needs of global biopharmaceutical companies of all sizes to speed the delivery of therapies to patients worldwide.